PICXEL was designed to evaluate the effects of long-term administration of a very low-dose combination of perindopril plus indapamide (perindopril/indapamide) vs ...
Berlin, Germany - Lowering blood pressure (BP) in stroke survivors using a combination of the ACE inhibitor perindopril (Aceon® - Solvay Pharmaceuticals) and indapamide (Indapamide® - Arcola Labs), a ...
This combination medication contains an angiotensin-converting enzyme (ACE) inhibitor and thiazide diuretic, prescribed for high blood pressure.
A fixed combination of perindopril (an ACE inhibitor) plus indapamide (a diuretic), available under the brand name Preterax, was evaluated in a randomized trial (Lancet. 2007;370:829-840). Patients ...
Review the side-effects of Perindopril and Indapamide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...
Please provide your email address to receive an email when new articles are posted on . ROME — Combining intensive glucose control using gliclazide with intensive blood pressure-lowering using a fixed ...
The REASON trial is an international, multicentre, randomised, double-blind investigation with two parallel groups. 16, 17, 18, 19, 20 This trial compared the ...
N.B. Please note that if you are ouside North America the embargo for Lancet press material is 0001 hours UK Time Friday 28th September 2001. Combination drug treatment to lower blood pressure could ...
The Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) trial was a double-blind, randomized, placebo-controlled trial performed at 215 centers in 20 ...
London, United Kingdom – 31 August 2024: A single-pill combination of four blood-pressure (BP)-lowering medications was significantly more effective than a combination of three medications, according ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. New analyses from the ADVANCE trial reveal independent ...